Daniel Saal is a clinician, scientist, inventor, and academic who has dedicated his career to treating addiction. He most recently served as Medical Director of Kaiser Permanente’s Chemical Dependence Program, where he managed a staff of MDs, NPs, psychologists, and other clinicians. Dr. Saal and his team handled treatment of addiction issues for a catchment of 420,000 patients in the San Francisco Bay Area.
Prior to entering clinical work, he spent six years as an academic, starting as a post- doc at Stanford University Department of Psychiatry, and going on to serve as a professor of medicine at Emory University. During this time, and throughout his career, Dr. Saal has published many articles in prestigious publications - one in particular found a common correlation amongst the neurophysiological pathways of all drugs of misuse - and is now widely cited in the literature. His research has also suggested novel pharmacologic treatment of stress and addiction. Dr. Saal has not only studied the neuroscience of addiction, but he has applied his findings to the clinical environment. For his research and throughout his career, Dr. Saal has received numerous grants and awards from both government agencies (e.g. the National Institutes of Health) and private industry (e.g. Pfizer Corporation). Dr. Saal received his MD and PhD from Yale University and his BS from the Massachusetts Institute of Technology.